newsfilter
← Latest News
Business Wire·

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

Reported total revenue of $102.3 million with 27% year-over-year growth in exome and genome revenue Reported exome and genome volume growth of 34% year-over-year Reported adjusted gross margin(1) of 69% and